Profile of inhaled glycopyrronium bromide as monotherapy and in fixed-dose combination with indacaterol maleate for the treatment of COPD

Chronic obstructive pulmonary disease (COPD) is a major cause of morbidity and mortality. The cornerstone of pharmacological treatment for COPD is bronchodilation. Inhaled glycopyrronium bromide is a long-acting muscarinic antagonist developed as a maintenance treatment for patients with COPD. Phase...

Descripción completa

Detalles Bibliográficos
Autores principales: Prakash, Anoop, Babu, K Suresh, Morjaria, Jaymin B
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2015
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4293295/
https://www.ncbi.nlm.nih.gov/pubmed/25609944
http://dx.doi.org/10.2147/COPD.S67758

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4293295/
https://www.ncbi.nlm.nih.gov/pubmed/25609944
http://dx.doi.org/10.2147/COPD.S67758

Ejemplares similares